Continued from page 1
Drug Therapy: A drug called Alimta, developed by Eli Lilly, has been shown to significantly increase life expectancy of patients and decrease symptoms of disease. It is only chemotherapy drug to be approved by Food and Drug Administration for treatment of patients with malignant pleural mesothelioma.
Gene Therapy: This mesothelioma treatment is currently in experimental stages. The process involves inserting a "suicide gene" directly into tumor. This gene makes cells sensitive to a normally ineffective drug called glanciclovir which destroys all cancer cells and leaves healthy cells unharmed.
Photodynamic Therapy: Still in its experimental stage, photodynamic therapy uses light to kill cancerous cells. The patient first receives a photosensitizer that only collects in cancerous cells. Fiberoptic cables are then placed in body in order to focus right frequency of light on tumor. The photosensitizer is then caused to produce a toxic oxygen molecule that kills cancer cell.
Immunotherapy: Also referred to as biological therapy, this mesothelioma treatment uses body's personal immune system to defend itself against mesothelioma. It has been discovered that immune system is capable of deciphering healthy cells from cancerous cells, and can thus eradicate those cells that cause cancer.
While treatment methods are still in developmental or experimental stages, there is hope that one day all mesothelioma victims will be freed from murderous hands of this fearsome disease.
Maggie Kay is a freelance writer from Montreal and is the head researcher and content manager of Mesothelioma Attorney Advice Center (www.maacenter.org).